High-dose intravenous cyclophosphamide therapy in severe SLE

Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report.

Lupus·2017

Burden of illness in systemic lupus erythematosus: results from a UK patient and carer online survey.

Lupus·2017

Alveolar haemorrhage in eosinophilic granulomatosis and polyangiitis (Churg-Strauss).

Clinical rheumatology·2014

The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice.

Lupus·2011

An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA.

Annals of the rheumatic diseases·2010

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial.

Arthritis and rheumatism·2010

Achievement of real-world adapted DORIS remission targets among patients with systemic lupus erythematosus initiating belimumab in the USA: A retrospective, observational, cohort study.

Lupus·2026

Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.

Lupus·2026

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.

Lupus·2026

CircSMURF2 alleviates cell apoptosis by binding DIABLO promote ubiquitination and its expression level and clinical significance in lupus nephritis.

Lupus·2026

Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort.

Lupus·2026

Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing.

Lupus·2026

Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first-time blood donors.

Transfusion·2026

Association between hematuria remission at 6 months and subsequent kidney outcomes in IgA nephropathy.

Journal of nephrology·2026

Thrombophilias associated with patent foramen ovale (PFO) in patients after an episode of cryptogenic stroke.

Future cardiology·2026

Impact of HLA-B leader matching on clinical outcomes of haploidentical hematopoietic stem cell transplantation in adult patients with acute leukemia, a retrospective cohort study.

Annals of medicine and surgery (2012)·2026

Tgfbr3 is required for the long-term maintenance of self-renewal potential in murine hematopoietic stem cells.

Blood science (Baltimore, Md.)·2026

Sickle red blood cell/Siglec-9 interactions contribute to neutrophil activation in SCD and are associated with survival.

Blood. Red cells & iron·2026

Related Experiment Videos

High-dose intravenous cyclophosphamide therapy in severe SLE

Related Concept Videos

Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report.

Burden of illness in systemic lupus erythematosus: results from a UK patient and carer online survey.

Alveolar haemorrhage in eosinophilic granulomatosis and polyangiitis (Churg-Strauss).

The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice.

An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA.

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial.

Achievement of real-world adapted DORIS remission targets among patients with systemic lupus erythematosus initiating belimumab in the USA: A retrospective, observational, cohort study.

Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.

Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.

CircSMURF2 alleviates cell apoptosis by binding DIABLO promote ubiquitination and its expression level and clinical significance in lupus nephritis.

Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort.

Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing.

Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first-time blood donors.

Association between hematuria remission at 6 months and subsequent kidney outcomes in IgA nephropathy.

Thrombophilias associated with patent foramen ovale (PFO) in patients after an episode of cryptogenic stroke.

Impact of HLA-B leader matching on clinical outcomes of haploidentical hematopoietic stem cell transplantation in adult patients with acute leukemia, a retrospective cohort study.

Tgfbr3 is required for the long-term maintenance of self-renewal potential in murine hematopoietic stem cells.

Sickle red blood cell/Siglec-9 interactions contribute to neutrophil activation in SCD and are associated with survival.

Related Experiment Videos

High-dose intravenous cyclophosphamide therapy in severe SLE

Related Concept Videos

Related Articles